Literature DB >> 18855632

Sustained transgene expression using MAR elements.

Niamh Harraghy1, Armelle Gaussin, Nicolas Mermod.   

Abstract

Matrix attachment regions (MARs) are DNA sequences that may be involved in anchoring DNA/chromatin to the nuclear matrix and they have been described in both mammalian and plant species. MARs possess a number of features that facilitate the opening and maintenance of euchromatin. When incorporated into viral or non-viral vectors MARs can increase transgene expression and limit position-effects. They have been used extensively to improve transgene expression and recombinant protein production and promising studies on the potential use of MAR elements for mammalian gene therapy have appeared. These illustrate how MARs may be used to mediate sustained or higher levels of expression of therapeutic genes and/or to reduce the viral vector multiplicity of infection required to achieve consistent expression. More recently, the discovery of potent MAR elements and the development of improved vectors for transgene delivery, notably non-viral episomal vectors, has strengthened interest in their use to mediate expression of therapeutic transgenes. This article will describe the progress made in this field, and it will discuss future directions and issues to be addressed.

Entities:  

Mesh:

Year:  2008        PMID: 18855632     DOI: 10.2174/156652308786071032

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  27 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

Review 2.  Programming DNA replication origins and chromosome organization.

Authors:  Christelle Cayrou; Philippe Coulombe; Marcel Méchali
Journal:  Chromosome Res       Date:  2010-01       Impact factor: 5.239

3.  Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver.

Authors:  Orestis Argyros; Suet Ping Wong; Constantinos Fedonidis; Oleg Tolmachov; Simon N Waddington; Steven J Howe; Marcello Niceta; Charles Coutelle; Richard P Harbottle
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

4.  Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction.

Authors:  Fabien Palazzoli; Solenne Bire; Yves Bigot; Florence Bonnin-Rouleux
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

5.  Expression of the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene under control of the 5'-regulatory sequence of the goat alpha-S1-casein gene with and without a MAR element in transgenic mice.

Authors:  I A Burkov; I A Serova; N R Battulin; A V Smirnov; I V Babkin; L E Andreeva; G A Dvoryanchikov; O L Serov
Journal:  Transgenic Res       Date:  2013-02-23       Impact factor: 2.788

6.  Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells.

Authors:  Zeynep Betts; Alan J Dickson
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

7.  An S/MAR-based L1 retrotransposition cassette mediates sustained levels of insertional mutagenesis without suffering from epigenetic silencing of DNA methylation.

Authors:  Danny Rangasamy
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

Review 8.  Pancreas-specific Cre driver lines and considerations for their prudent use.

Authors:  Mark A Magnuson; Anna B Osipovich
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

9.  POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.

Authors:  Sarah P Read; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

10.  Expression of Pdx1 mediates differentiation from mesenchymal stem cells into insulin-producing cells.

Authors:  Huijuan Yuan; Jie Li; Ning Xin; Zhigang Zhao; Guijun Qin
Journal:  Mol Biol Rep       Date:  2010-03-21       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.